Home › Therapeutic areas › Oncology › Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (2 companies)
Companies with an active program in Chronic Lymphocytic Leukemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | $341M | 12 |
| NRIX | Nurix Therapeutics | ImmunologyNeurology+1 | 1 | Phase 3 | $1.67B | 13 |
No companies match.